Welcome!

@CloudExpo Authors: Elizabeth White, Zakia Bouachraoui, Liz McMillan, Pat Romanski, Roger Strukhoff

News Feed Item

Effective Drug Development Metrics Link Operations With Strategy, According to Tufts Center for the Study of Drug Development

Effective Drug Development Metrics Link Operations With Strategy, According to Tufts Center for the Study of Drug Development

BOSTON, MA -- (MARKET WIRE) -- 06/10/08 -- Research-based drug companies looking to streamline the development of new medicinal products should adopt metrics that link their R&D activities with business strategy, according to the Tufts Center for the Study of Drug Development.

"To be most useful to senior management, metrics should focus on in-depth analyses of selected performance measures and provide strategic context and implications. And to be accepted throughout the organization, they need to be easily understood," said Tufts CSDD Director Kenneth I Kaitin, citing key points made at a roundtable discussion of drug industry leaders recently convened by Tufts CSDD.

The roundtable highlighted current best practices in drug development metrics, an issue of strong concern to research-based pharmaceutical and biotech companies, since many face growing pressure by investors and other stakeholders to reduce development times and lower R&D costs.

"To set R&D strategy and make other key decisions, senior managers need to understand how internal company targets relate to external benchmarks. The right metrics make this connection," said Kaitin.

The meeting, part of Tufts CSDD's Executive Forum Roundtable Series, was organized to identify ways to extract full value from metrics.

According to those participating in the roundtable, good metrics:

--  Should be easily obtained, quantitatively and qualitatively
    measurable, and historically applicable.

--  Identify areas for major improvement, determine the amount of change
    required, provide motivation for change, and provide the basis for
    monitoring and tracking results.

--  Help people understand if their probability assessments, cycle times,
    forecasts, and other key projections are overly optimistic or conservative.

--  Enable senior managers to see intended and unintended consequences of
    the company's R&D strategy.
    

SCHEDULED R&D MANAGEMENT ROUNDTABLES

Upcoming Tufts CSDD Roundtable meetings in 2008 will focus on the following:

--  Sept. 11 - Optimizing Protocol Design -- Strategies to Improve
    Clinical Research Performance
--  Nov. 6 - Assessing Change and Opportunity in the Phase I Landscape
    

To register, call 617-636-2170.

ABOUT THE TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT

The Tufts Center for the Study of Drug Development (http://csdd.tufts.edu) at Tufts University provides strategic information to help drug developers, regulators, and policy makers improve the quality and efficiency of pharmaceutical development, review, and utilization. A core element of the center's educational efforts, the Tufts CSDD Institute for Professional Development, produces the Executive Forum Roundtable Series, along with postgraduate level courses, training workshops, symposia, and public forums.

Add to DiggBookmark with del.icio.usAdd to Newsvine

Contact:
Tufts Center for the Study of Drug Development
Charlene Neu
617-636-2187
Email Contact

Business Communication Strategies
Peter Lowy
617-734-9980
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

CloudEXPO Stories
The platform combines the strengths of Singtel's extensive, intelligent network capabilities with Microsoft's cloud expertise to create a unique solution that sets new standards for IoT applications," said Mr Diomedes Kastanis, Head of IoT at Singtel. "Our solution provides speed, transparency and flexibility, paving the way for a more pervasive use of IoT to accelerate enterprises' digitalisation efforts. AI-powered intelligent connectivity over Microsoft Azure will be the fastest connected path for IoT innovators to scale globally, and the smartest path to cross-device synergy in an instrumented, connected world.
There are many examples of disruption in consumer space – Uber disrupting the cab industry, Airbnb disrupting the hospitality industry and so on; but have you wondered who is disrupting support and operations? AISERA helps make businesses and customers successful by offering consumer-like user experience for support and operations. We have built the world’s first AI-driven IT / HR / Cloud / Customer Support and Operations solution.
ScaleMP is presenting at CloudEXPO 2019, held June 24-26 in Santa Clara, and we’d love to see you there. At the conference, we’ll demonstrate how ScaleMP is solving one of the most vexing challenges for cloud — memory cost and limit of scale — and how our innovative vSMP MemoryONE solution provides affordable larger server memory for the private and public cloud. Please visit us at Booth No. 519 to connect with our experts and learn more about vSMP MemoryONE and how it is already serving some of the world’s largest data centers. Click here to schedule a meeting with our experts and executives.
Darktrace is the world's leading AI company for cyber security. Created by mathematicians from the University of Cambridge, Darktrace's Enterprise Immune System is the first non-consumer application of machine learning to work at scale, across all network types, from physical, virtualized, and cloud, through to IoT and industrial control systems. Installed as a self-configuring cyber defense platform, Darktrace continuously learns what is ‘normal' for all devices and users, updating its understanding as the environment changes.
Codete accelerates their clients growth through technological expertise and experience. Codite team works with organizations to meet the challenges that digitalization presents. Their clients include digital start-ups as well as established enterprises in the IT industry. To stay competitive in a highly innovative IT industry, strong R&D departments and bold spin-off initiatives is a must. Codete Data Science and Software Architects teams help corporate clients to stay up to date with the modern business digitalization solutions. Achieve up to 50% early-stage technological process development cost cutdown with science and R&D-driven investment strategy with Codete's support.